Application no. and date | 19708817.2 (espacenet) (Federated) (European Patent Register), 20190228 | Patent/reg. no. and date | DK/EP 3759083, 20220504 | Publication date | 20210106 | Priority no. and date | EP 18159583, 20180301 | EP pub. no. and date |
EP 3759083 20210106 | Effective date | | Applicant/owner | Janssen Sciences Ireland Unlimited Company, Barnahely
Ringaskiddy, Co Cork, IE | Applicant ref. no. | 1637225 | Inventor | JONCKERS, Tim, Hugo, Maria, Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, MC GOWAN, David, Craig, Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, EMBRECHTS, Werner, Constant, Johan, Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, COOYMANS, Ludwig, Paul, Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse, BE, RABOISSON, Pierre, Jean-Marie, Bernard, Avenue Denis Diderot 5
1300 Wavre, BE, GUILLEMONT, Jérôme, Émile, Georges, Janssen-Cilag 1 rue Camille Desmoulins, TSA 91003
92787 Issy-les-Moulineaux Cedex 9, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/517 (2006.01) , A61P 1/16 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) , A61P 37/06 (2006.01) , C07D 239/95 (2006.01) | Title | 2,4-DIAMINOQUINAZOLINDERIVATER OG ANVENDELSE DERAF TIL BEHANDLING AF VIRUSINFEKTIONER, CANCER ELLER ALLERGIER | Int. application no. | EP2019054941 | Int. publication no. | WO2019166532 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|